Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar.

Goran PetrovskiFawziya Al KhalafKhalid HussainJudith CampbellAhmed El Awwa

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)

Our results show that CSII may significantly improve glucose control in T1D children and adolescents who use a standardized protocol. A reduction of HbA1c by - 1.6% was achieved at 1 year after CSII initiation. These results need to be confirmed in a study with a longer duration.

Keyphrases

type diabetes
glycemic control
blood glucose
randomized controlled trial
low dose
cardiovascular disease
insulin resistance
weight loss
adipose tissue
metabolic syndrome